Skadden, Latham Steer 2 Follow-On Offerings Raising $152M
Chinese wearable device maker Huami Corp., advised by Skadden, and cancer-focused biotechnology firm Gritstone Oncology, advised by Latham & Watkins LLP, raised more than $152 million combined through follow-on offerings that...To view the full article, register now.
Already a subscriber? Click here to view full article